pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
LEADING · news · pharmadog
← back to LEADING
News mentioning LEADING
653
stories
Jul 30, 26
Is it safe to drink Red Bull and alcohol? Questionable research tied to energy drink giant has shaped policy
stat
Jul 29, 26
FDA advisers vote against approval of Capricor’s DMD therapy in chaotic adcomm meeting
biospace
Jul 29, 26
FDA reviewers vote against approval of Capricor’s DMD therapy in chaotic adcomm meeting
biospace
Jul 29, 26
NSF testing new Ph.D. model giving trainees academic and industry experience
stat
Jul 29, 26
Capricor Duchenne cell therapy voted down by FDA panel
biopharma dive
Jul 29, 26
AbCellera, Vertex partner on next-gen T-cell engagers
biopharma dive
Jul 29, 26
Biogen shifts M&A strategy as Apellis acquisition pushes revenue above analyst expectations
biospace
Jul 29, 26
Merck posts—then pulls—trial plan for PD-1xVEGF and TROP2 ADC combination
fiercebiotech
Jul 29, 26
STAT+: Pharmalittle: We’re reading about a fugitive who became a biotech exec, a hospital suing Lilly, and more
stat
Jul 29, 26
STAT+: Why benchmarking clinical LLMs from OpenEvidence, Doximity is complicated
stat
Jul 29, 26
Incyte cuts early-stage cancer drug to focus on next-gen programs
biospace
Jul 29, 26
Former Recursion CEO Chris Gibson joins Dimension as operating partner
endpoints
Jul 29, 26
Opinion: The VA could help America win the biotechnology race with China
stat
Jul 29, 26
STAT+: In the biotech industry, a most-wanted fugitive was long hiding in plain sight
stat
Jul 29, 26
Vertex’s latest autoimmune TCE play involves $28M upfront to AbCellera
fiercebiotech
Jul 28, 26
STAT+: American Diabetes Association, facing calls for resignations, asks for patience
stat
Jul 28, 26
Webinar: Building the Intelligence Engine for Drug Discovery R&D Teams
biospace
Jul 28, 26
FDA offers updated guidance for generics of weight loss blockbusters
endpoints
Jul 28, 26
Altimmune rises as GLP-1/glucagon drug curbs heavy drinking in mid-stage study
biospace
Jul 28, 26
An eye drug biotech banks $118M and stocks its executive suite
biopharma dive
Jul 28, 26
Guardant Health taps Patrick Dempsey for emotional colorectal cancer awareness video
fiercebiotech
Jul 28, 26
Opinion: STAT+: Dementia finally has a business model
stat
Jul 28, 26
STAT+: From ‘lost cause’ to gold rush: Biotechs swarm to cure AATD
stat
Jul 27, 26
Argenx to acquire Forte in $2.2B deal for ‘differentiated’ immune drug
biopharma dive
Jul 27, 26
Sarepta names former AbbVie R&D exec Michael Severino as next CEO
biospace
Jul 27, 26
Sarepta, in search of a turnaround, taps ex-AbbVie exec Severino as CEO
biopharma dive
Jul 27, 26
STAT+: Sarepta names Michael Severino, former Tessera CEO, as new chief executive
stat
Jul 27, 26
AstraZeneca has no plans to ramp up dealmaking in wake of Wainua failure
biospace
Jul 27, 26
FDA approves Freenome colorectal cancer blood test to be marketed by Abbott
fiercebiotech
Jul 27, 26
After missed endpoint, Gossamer and Chiesi pull the plug on PAH drug collaboration
fiercebiotech
← prev
page 14 of 22
next →
